WE ARE BIOCT


New Haven’s Bioscience Footprint Expands

Construction begins on 101 College Street,
a 10-story tower that will add 500,000 s/f
of new lab, research and meeting space.

EXCLUSIVE DISCOUNTS

New England Edge offers you substantial savings on the products and services you use the most.

Explore Offers

JOIN BIOCT

A diverse community of innovators committed to the growth and sustainability our bioscience community.

Join Now

EQUITY, DIVERSITY & INCLUSION

Be a part of the solution in helping find new ways to build inclusivity.

Learn More

CAREER CENTER

Your source for today’s talent, job opportunities and career development.

Career Center

BioCT is the voice of Connecticut’s bioscience industry.

Dedicated to the growth of a vibrant bioscience ecosystem, our organization connects companies, institutions, entrepreneurs, investors, government, service providers, and other passionate, dedicated people to improve patients’ lives and public health.

Upcoming Events

2
Academic Bioscience R&D
4
Bioscience Patents
561
NIH Funding in 2018
4
Bioscience Venture Capital
4
Most Innovative State
8
Science & Engineering Doctorates

BioCT is grateful for the support of our partners & sponsors.

Your exclusive member benefits.

We’ve partnered with MassBio to bring you an even-bigger purchasing program featuring the supplier discounts their members enjoy.
Save big on everything you need, from travel to office products to lab supplies and more.

Click for Discounts

BioCT’s catalyst for
innovation and entrepreneurship.

Innovation Commons is an incubator dedicated to talent development, job creation and the build of high value, sustainable businesses.

GOVERNMENT ADVOCACY

Your voice in Hartford
and Washington.

BioCT keeps policy makers abreast of the latest developments and changing needs of the bioscience community, ensuring policy alignment at the state and federal level.

Read More

Newsroom

Alexion now officially part of AstraZeneca

New Haven-born Alexion Pharmaceuticals, whose blockbuster blood-disorder drug Soliris made it one of the Elm City’s biggest biotech success stories a decade ago, is now...

InveniAI in collaboration with PRISM BioLab

InveniAI® has completed a milestone in its collaboration with PRISM BioLab. The milestone marks completion of the identification and validation of a small molecule drug candidate...

Yale seen as growth engine for New Haven

Lauren Zucker is Yale University’s associate vice president for New Haven Affairs and University Properties. New Haven BIZ recently spoke with Zucker about Yale’s efforts to drive...